B2DB — Who said what, where, and when

Jordi Rodon

University of Texas MD Anderson Cancer Center

Jordi Rodon is listed as University of Texas MD Anderson Cancer Center. Jordi is scheduled to speak at EORTC-NCI-AACR Symposium 2026 (ENA 2026) on 18 November 2026.

Compiled from published conference agendas; not yet confirmed by Jordi. Is this you? Claim this profile.

About

BIOGRAPHICAL SKETCH NAME: Rodon Ahnert, Jordi POSITION TITLE: Associate Professor of Investigational Cancer Therapeutics, Clinical Head of the Molecular Therapies Research Unit (the Phase I Unit) EDUCATION/TRAINING FIELD OF STUDY Universitat Autonoma de Barcelona, Barcelona, Spain, PhD, 2015, Medicine Universitat de Barcelona, Barcelona, Spain, MS, 2008, Experimental Medicine The Institute for Drug Development, Cancer Therapy and Research Center, and the University of Texas, San Antonio, TX, Clinical research fellow 2005-2008, Clinical Fellowship, Advanced Oncology Drug Development Institut Català d'Oncologia, Barcelona, Spain Residency Fellowship, 2001-2005, Medical Oncology Universitat Autonoma de Barcelona, Barcelona, Spain, MD, 2000, Medicine Personal Statement I have specialized in early drug development, biomarker discovery, personalized cancer medicine, and neuro-oncology. With my new position at MD Anderson’s Investigational Cancer Therapeutics and Medical Director, Institute f

Upcoming

EORTC-NCI-AACR Symposium 2026 (ENA 2026) 18 November 2026 – 20 November 2026